6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate
C22H21ClN4O3 — CID 172853860
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate
6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate (PubChem CID 172853860) has the molecular formula C22H21ClN4O3 and a molecular weight of 424.89 g/mol. Its IUPAC name is 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate.
Molecular Properties
| Compound Name | 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate |
|---|---|
| PubChem CID | 172853860 |
| Molecular Formula | C22H21ClN4O3 |
| Molecular Weight | 424.89 g/mol |
| Exact Mass | 424.13 |
| IUPAC Name | 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-1H-quinolin-2-one;methyl 3-chloropyridine-2-carboxylate |
| SMILES | COC(=O)c1ncccc1Cl.NCc1cncc(-c2ccc3c(c2)CCC(=O)N3)c1 |
| InChI | InChI=1S/C15H15N3O.C7H6ClNO2/c16-7-10-5-13(9-17-8-10)11-1-3-14-12(6-11)2-4-15(19)18-14;1-11-7(10)6-5(8)3-2-4-9-6/h1,3,5-6,8-9H,2,4,7,16H2,(H,18,19);2-4H,1H3 |
| InChIKey | YKWSZUGNQPJGJB-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 107.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.89 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172853860 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.